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Abstract
Background: Routine repeat testing of critical laboratory values is very common these days to increase their
accuracy and to avoid reporting false or infeasible results. We figure that repeat testing of critical laboratory
values has any benefits or not.
Methods: We examined 2233 repeated critical laboratory values in 13 different hematology and chemistry
tests including: hemoglobin, white blood cell, platelet, international normalized ratio, partial thromboplastin
time, glucose, potassium, sodium, phosphorus, magnesium, calcium, total bilirubin and direct bilirubin. The
absolute difference and the percentage of change between the two tests for each critical value were calculated
and then compared with the College of American Pathologists/Clinical Laboratory Improvement Amendments
allowable error.
Results: Repeat testing yielded results that were within the allowable error on 2213 of 2233 specimens
(99.1%). There was only one outlier (0.2%) in the white blood cell test category, 9 (2.9%) in the platelet test
category, 5 (4%) in the partial thromboplastin time test category, 5 (4.8%) in the international normalized ratio
test category and none in other test categories.
Conclusion: Routine, repeat testing of critical hemoglobin, white blood cell, platelet, international normalized
ratio, partial thromboplastin time, glucose, potassium, sodium, phosphorus, magnesium, calcium, total bilirubin
and direct bilirubin results does not have any benefits to increase their accuracy.
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Introduction
Nowadays, laboratory services play a ma-
jor role in optimizing patient care. In some
circumstances, increased laboratory use is
allowed such as: 1. Correct and prompt di-
agnoses can be made. 2. Suitable treatments
can be selected and achieved. 3. Better
prognoses can be established and 4. The
duration of the patient’s hospitalization can
be shortened (1-4).
Repeat testing usually occurs for the fol-
lowing reasons: 1. Previous test results are
not available or the physician does not
know about them (5-8), nevertheless, in-
formation technology can display previous
test results and reduce useless repeat testing
(9,10). 2. A performed test, repeats again
for the patient after admission to hospital
(11). 3. Pre-analytic errors occur and there
is a need for re-sampling the specimen
(12,13). 4. The patient asks physicians to
repeat a test again (14,15).
In the early decades of 1970, Lundberg
and his colleagues at the Los Angeles
County/University of Southern California
Medical Center introduced the term “panic
values” for those kinds of laboratory results
that can predict high risk danger for the pa-
tients and be life-threatening unless the
physicians do some immediate possible in-
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tervention. After some criticism that physi-
cians should not be panic for any cause,
they changed it to “critical values”
(12,13,16).
In time, reporting of critical laboratory
test values became an important operation
of clinical laboratory utilization and has
been adapted worldwide including some
laboratory accreditation agencies, such as
the College of American Pathologists
(CAP) and the Joint Commission on Ac-
creditation of Healthcare Organizations
(JCAHO) that have made it part of the re-
quirements for laboratory accreditation
(17,18). They require laboratories to define
their own list of critical test values accord-
ing to their national safety conditions and
an authentic system to report of such results
to patient’s caregivers (18-20).
The JCAHO announced improving the
process of critical value reporting a Nation-
al Patient Safety Goal for the years 2004
through 2006. Also it has defined critical
test results as not only laboratory tests but
also imaging, electrocardiograms, and other
diagnostic proceedings (17).
In the early years of automatic laboratory
procedures, there were no advanced Labor-
atory information system (LIS) technology
and instruments with sensitive level sensors
and clot detectors. Therefore, it was ac-
ceptable to repeat critical test values to pre-
vent inaccurate results created due to com-
mon problems such as misidentification of
the sample, fibrin clots, or insufficient
samples. But nowadays repeating them is
necessary only when we have uncertain re-
sults otherwise it is an unnecessary work to
do (21). As a recent summary of data from
a College of American Pathologists (CAP)
Q-Probes survey shows that pre-analytic
and post analytic errors representing 85%
to 92% of all clinical laboratory related er-
rors, while analytic issues include only 8%
to 15% of them (22,23). It also approved
that 60.8 percent of laboratories still repeat
critical values in chemistry, and 52.6 per-
cent always repeat critical values in hema-
tology (24).
On the other hand, unnecessary tests may
have some disadvantages such as: 1. Per-
forming inappropriate treatments. 2. Caus-
ing fear and anxiety in patients by false
positive results, or inducing a large number
of further unnecessary testing (25,26). 3.
Increased costs for the patients and health
care system which could lead to other in-
competencies in health care delivery (27-
31). 4. Delay reporting to caregiver for ex-
ample, The CAP Q-Probes survey ex-
pressed that laboratory routine repeat test-
ing can delay reporting by 10 to 14 minutes
without increasing the accuracy of the re-
sults (24,31,32).
So far, several studies have been con-
ducted recently about the routine repeat
testing of critical values in laboratories and
its possible effect on increasing accuracy of
the results, such as: 1. Chima et al’s study
in 2007 on 580 repeated tests in hematolo-
gy, coagulation, and chemistry testing (21).
2. Toll et al’s study in 2010 on 500 consec-
utive critical results in 5 different hematol-
ogy and coagulation tests (31). 3. Deetz et
al’s study in 2011 on 3162 critical results
(33). They all reported that routine repeat-
ing critical test values did not offer any ad-
vantage over single testing in improving
results accuracy.
There has not been any study about de-
termining the effect of routine repeat test-
ing of critical values in laboratory tests in
Iran. Moreover, the international studies on
this subject mostly cover a limited range of
laboratory tests. Therefore, we conducted
our research in a way that covers various
tests to overcome this shortcoming of exist-
ing literature. Another incentive for our re-
search is the fact that the majority of labor-
atories in Iran, especially the ones in educa-
tional hospitals apply routine repeat testing
of critical values as their regular method.
This method is time consuming and expen-
sive, so unless they add significant prog-
nostic information they can be avoided.
Our goal was to determine the effect of rou-
tine repeat testing of critical values in 13
different hematology, coagulation, and rou-
tine chemistry tests.
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Methods
Hazrat Rasoul-e-Akram Hospital is a 426-
bed Hospital in Tehran. Specialty services
at our hospital include internal medicine,
cardiology, neurology, neurosurgery, pedi-
atrics, ophthalmology, ENT, gynecology
and obstetrics and emergency. In our hospi-
tal we repeat critical laboratory test values
routinely to verifying them to ensure their
accuracy before reporting them to the phy-
sician. This repeating can be performed on
the same collected specimen or on the re-
collected one.
Tests examined were Hemoglobin
(HGB), white blood cell count (WBC),
platelet count (PLT), international normal-
ized ratio (INR), partial thromboplastin
time (PTT) for hematology laboratory and
glucose (Glc), potassium (K), sodium (Na),
phosphorus (P), magnesium (Mg), calcium
(Ca), total bilirubin (total bil) and direct
bilirubin (direct bil) for chemistry laborato-
ry. Hematology tests were performed on
ethylenediaminetetraacetic acid (EDTA) -
anticoagulated blood specimens on the
Sysmex KX 21 analyzer. For sodium and
potassium tests we used Ion Selective Elec-
trode (ISE) method on Microlyte analyzer.
Chemistry tests were performed on serum
specimens on the Hitachi 902 analyzer, and
coagulation tests were performed on citrat-
ed blood specimens and analyzed by manu-
al method. Repeat runs were performed on
the same analyzer. All analyzers were
placed under calibration and quality control
constantly. We created a report to retrieve
only the repeated critical values tests not
any repeated testing. The data captured in
these reports included date, patient ID, age
and gender of patients, initial result, repeat-
ed result, repeated test was performed in
which sample: the same collected specimen
or on the re-collected one. We collect these
data for over a year from August 22, 2011
to August 22, 2012.
Medical laboratory staff was highly quali-
fied and they have had over five years of
experience. We also directed them on the
way that the tests results should be collect-
ed and reported.
The critical laboratory test values were
collected from patients with a wide variety
of clinical complaints including malignan-
cies, infections, autoimmune disorders,
traumas, etc. The absolute value and the
percentage of change between the 2 test
runs for each critical value were calculated
and averaged for each test category and
then compared to the College of American
Pathologists/Clinical Laboratory Improve-
ment Amendments (CAP/CLIA) allowable
errors. If the absolute difference or the per-
centage of change between the repeated
value and the initial result was greater than
CAP/CLIA allowable error, it was assumed
an outlier. The CAP/ CLIA allowable er-
rors and critical values for the tests are
shown in Table 1.
Statistical analysis
All statistical analysis was done by
SPSS19. Absolute Difference, Mean, and
Percentage of change were calculated as
follows:
Absolute Differenc =│Initial value-Repeated value│
Mean = (Initial test value+Repeated test value)/ 2
Percentage of Change = (Absolute Difference/ Ini-
tial test value) ˟ 100
Results
Hemoglobin (HGB): Among the 348
HGB critical values, the repeat values of
122 specimens (35.06%) had equal results
to the initial test run.
White Blood Cell Count (WBC): Among
the 469 WBC critical values, the repeat
values of 171 specimens (36.46%) had
equal results to the initial test run.
Platelet Count (PLT): Among the 309
PLT critical values, the repeat values of 95
specimens (30.74%) had equal results to
the initial test run.
International Normalized Ratio (INR)
International Normalized Ratio (INR):
Among the 104 INR critical values, the re-
peat values of 27 specimens (25.96%) had
Repeating of critical values
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equal results to the initial test run. In    this
category, 69 repeating tests (66.35%) were
performed on the re-collected sample.
Partial Thromboplastin Time (PTT):
Among the 126 PTT critical values, the re-
peat values of 13 specimens (10.32%) had
equal results to the initial test run. In this
category, 86 repeating tests (68.25%) were
performed on the same collected sample,
and 40 repeating tests (31.75%) were per-
formed on the re-collected sample.
Phosphorus (P): Among the 82 P critical
Table 1.  The CAP/ CLIA allowable errors and critical values
Allowable ErrorCritical valueTest
+/- 7%< 7 or > 20 g/dLHemoglobin
+/- 25%< 30000 or > 950000 per/mLPlatelet
+/- 15%< 2000 or > 25000 per/mLWhite Blood Cell
+/- 15%< 20 or > 106 secPartial Thromboplastin Time
+/- 15%> 5International Normalized Ratio
+/- 6 mg/dL  or  10%< 50 or > 450 mg/dLGlucose
+/- 4 mmol/L< 125 or > 150 mmol/LSodium
+/- 0/5 mmol/L< 3 or > 5/9 mmol/LPotassium
+/- 1 mg/dL< 6 or > 14 mg/dLCalcium
+/- 25%< 1 or > 4/5 mg/dLMagnesium
+/- 0/4 mg/dL or 20%>18 mg/dLTotal Bilirubin
+/- 0/4 mg/dL or 20%> 1/8 mg/dLDirect Bilirubin
+/- 0/3  mg/dL< 1 mg/dLPhosphorus
Table 2. The Mean Absolute Difference And Percentage of Change Between 2 Testing Runs For Each Test Category
Test Subgroups No. of spec-
imens
Result Range Result
Mean
Mean Abso-
lute Differ-
ence
Mean Per-
centage
of Change
HGB (g/dL) All specimens 348 - - 0.16 2.3%
HGB < 7 329 2.4-6.9 6.08 0.13 2.26%
HGB > 20 19 20.1-25 22.1 0.62 2.84%
WBC (per/mL) All specimens 469 - 152.45 2.25%
WBC < 2000 223 200-1950 1243.5 52.47 3.91%
WBC>25000 246 25100-123000 30761.8 243.09 0.75%
PLT (per/mL) All specimens 309 - - 1747.57 7.15%
PLT < 30000 285 1000-29000 16977.19 1126.3 7.68%
PLT>950000 24 952000-1310000 1001104.2 9125 0.84%
INR All specimens 104 5.1-7 5.56 0.22 3.87%
same sample 69 5.1-7 5.59 0.26 4.63%
re-collected sample 35 5.1-6.5 5.5 0.13 2.37%
PTT (sec) All specimens 126 107-136 116.83 3.87 3.34%
same sample 86 107-136 116.8 3.83 3.3%
re-collected sample 40 107-130 116.91 3.98 3.42%
P (mg/dL) All specimens 82 0.3-0.9 0.76 0.05 7.99%
Glc (mg/dL) All specimens 109 - - 2.04 1.62%
Glc < 50 38 29-49 42.91 1.5 3.73%
Glc > 450 71 451-513 467.49 2.32 0.49%
K (mmol/L) All specimens 118 - - 0.06 1.81%
K < 3 90 2.5-2.9 2.8 0.06 2.13%
K > 5.9 28 6-6.2 6.05 0.05 0.77%
Mg (mg/dL) All specimens 87 - - 0.05 3.03%
Mg < 1 60 0.6-0.9 0.83 0.03 3.34%
Mg > 4.5 27 4.6-5.4 4.89 0.11 2.35%
Na (mmol/L) All specimens 124 - - 0.46 0.37%
Na < 125 102 120-124 122.99 0.49 0.4%
Na > 150 22 151-153 151.25 0.32 0.21%
Ca (mg/dL) All specimens 106 - - 0.12 1.63%
Ca < 6 63 5-5.9 5.53 0.12 2.15%
Ca > 14 43 14.1-16.1 14.74 0.13 0.88%
Total bil (mg/dL) All specimens 131 18.5- 40.5 26.71 0.19 0.74%
Direct bil (mg/dL) All specimens 120 1.9-4.5 2.93 0.19 6.49%
HGB, Hemoglobin; WBC, White Blood Cell; PLT, Platelet; INR, International Normalized Ratio; PTT, Partial Thromboplastin Time; P,
Phosphorus; Glc, Glucose; K, Potassium; Mg, Magnesium; Na, Sodium; Ca, Calcium; bil, Bilirubin; sec, seconds.
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values, the repeat values of 52 specimens
(63.4%) had equal results to the initial test
run.
Glucose (Glc): Among the 109 Glc criti-
cal values, the repeat values of 17 speci-
mens (15.6%) had equal results to the ini-
tial test run.
Potassium (K): Among the 118 K critical
values, the repeat values of 62 specimens
(52.5%) had equal results to the initial test
run.
Magnesium (Mg): Among the 87 Mg crit-
ical values, the repeat values of 56 speci-
mens (64.37%) had equal results to the ini-
tial test run
Sodium (Na): Among the 124 Na critical
values, the repeat values of 76 specimens
(61.29%) had equal results to the initial test
run.
Calcium (Ca): Among the 106 Ca critical
values, the repeat values of 36 specimens
(33.96%) had equal results to the initial test
run.
Total Bilirubin: Among the 131 Bil total
critical values, the repeat values of 22 spec-
imens (16.8%) had equal results to the ini-
tial test run.
Direct Bilirubin: Among the 120 Bil di-
rect critical values, the repeat values of 20
specimens (16.67%) had equal results to
the initial test run.
The mean absolute difference and per-
centage of change between two testing runs
for each test category and subgroups of
them are tabulated in Table 2.
The lowest absolute difference was 0.05
mg/dL, obtained for the Mg and P results,
and the highest absolute difference was
1747.57 per/mL, obtained for the PLT re-
sults. Among the subgroups the lowest ab-
solute difference was 0.03 mg/dL, obtained
for the Mg<1 mg/dL results, and the high-
est absolute difference was 9125 per/mL,
obtained for the PLT>950000 results.
The lowest percentage of change was
0.37%, obtained for the Na results, and the
highest percentage of change was 7.99%,
obtained for the P results. Among the sub-
groups the lowest percentage of change was
0.21%, obtained for the Na>150 mmol/L
results and the highest absolute difference
was 7.99%, obtained for the P results.
The specifics of outliers are shown in Ta-
ble 3. There was 1 outlier (0.2%) in the
WBC test category with the absolute differ-
ence of 200 per/mL, and a mean value of
1400 per/mL, 9 (2.9%) in the PLT test cat-
egory with the absolute differences in the
range of 1000 to 4000 per/mL, and the
mean values in the range of 3500 to 18000
per/mL. 5 (4.8%) in the INR test category
with the absolute differences in the range of
Table 3. Specifics of Outliers
Test Total
Specimens,
No
Outliers,
No. (%)
Allowable
Error
Run 1 Run 2 Mean Absolute
Difference
Percentage
of Change
Same or
recollected
sample
White Blood
Cell  (per/mL)
469 1(0.2%) +/-15% 1300 1500 1400 200 15.38% Same
Platelet
(per/mL)
309 9(2.9%) +/-25% 8000 10000 9000 2000 25% Same
7000 9000 8000 2000 28.57% Same
4000 5000 4500 1000 25% Same
7000 11000 9000 4000 57.14% Same
3000 4000 3500 1000 33.33% Same
4000 5000 4500 1000 25% Same
5000 7000 6000 2000 40% Same
16000 20000 18000 4000 25% Same
7000 9000 8000 2000 28.57% Same
International
Normalized
Ratio
104 5(4.8%) +/-15% 5.2 6.2 5.7 1 19.23% Same
6 7 6.5 1 16.67% Same
5.2 6 5.6 0.8 15.38% Same
5.3 6.1 5.7 0.8 15.09% Same
5.2 6.2 5.7 1 19.23% Same
Partial Throm-
boplastin Time
(sec)
126 5(4%) +/-15% 118 136 127 18 15.25% Same
108 125 116.5 17 15.74% Same
107 124 115.5 17 15.89% Same
107 124 115.5 17 15.89% Recollected
113 130 121.5 17 15.04% Recollected
Repeating of critical values
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0.8 to 1, and the mean values in the range
of 5.6 to 6.5. 5 (4%) in the PTT test catego-
ry with the absolute differences in the range
of 17 to 18 seconds, and the mean values in
the range of 115.5 to 127 seconds, and none
in other 9 test categories.
Out of 20 (100%) samples with signifi-
cant difference (outlier) only two (10%) of
them were among the tests performed on
recollected samples, the rest were per-
formed on the same samples. Both of these
cases belong to PTT test which means two
of 126 tests (1.6%) and two of 40 recollect-
ed samples of this test (5%) showed signif-
icant differences. Recollected samples were
only available for PTT and INR. Therefore,
we do not have enough evidence to con-
clude whether recollecting samples have
significant effects on the results.
Discussion
As we mentioned before, recent studies
showed that the routine repeat testing of
critical test values does not have any ad-
vantage with recent year’s laboratory au-
tomated equipments (21,31). In a recent
study, Chima et al collected a total of 580
repeated tests for potassium, glucose, plate-
let count, and activated partial thrombo-
plastin time and expressed that 95.3% of
repeated testing for critical values was
within their acceptable difference (21). An-
other study examined 500 consecutive crit-
ical results for 5 different hematolo-
gy/coagulation tests.   By   using   their
laboratory’s   acceptable tolerance limits
for reruns (ATLR), Toll et al expressed that
0% to 2.2% of the repeated values for these
tests were outside of their acceptable range
(31). Also, in 2011 Deetz et al examined
2162 critical results in chemistry laboratory
and they found that 2.8% of the repeated
values were outside of the CAP/CLIA Total
allowable errors (33). They all concluded
that repeated testing for critical values did
not offer an advantage in hematology,
chemistry, and coagulation settings.    To
determine the effect of routine repeat test-
ing of critical values, we examined 2233
specimens from 13 different hematology,
coagulation, and chemistry tests (348 HGB
critical results, 469 WBC critical  results,
309   PLT   critical  results, 104 INR criti-
cal results, 126 PTT critical results, 82 P
critical results, 109 Glc critical results, 118
K critical results, 87 Mg critical results,
124 Na critical results, 106 Ca critical re-
sults, 131 total Bilirubin critical results, and
120 direct Bilirubin critical results). We
calculated the absolute difference and the
percentage of change between the initial
and repeated value for each of them and
then compared with CAP/CLIA Total al-
lowable errors. If the absolute difference or
the percentage of change between the re-
peated value and the initial result was
greater than CAP/CLIA allowable error, it
was assumed an outlier.
From 2233 repeated test values, a total of
20 outliers were detected (99.1%) in which
the difference between 2 testing runs ex-
ceeded the CAP/CLIA limits for allowable
error. The test results outside this range in-
cluded: There was only one outlier (0.2%)
in the WBC test category, 9 (2.9%) in the
PLT test category, 5 (4%) in the PTT test
category, 5 (4.8%) in the INR test category
and none in other test categories. None of
the critical test values became noncritical
on repeat testing.
The significant difference between the in-
itial result and the repeated result in the
PTT test category might be attributed to
instability of specimens from patients on
heparin therapy. Sometimes, heparin inhibi-
tion by platelet factor 4 (released by acti-
vated platelets in the specimen) makes the-
se patient’s results poor reproducible (34).
In the PLT test category, it might be at-
tributed to clot formation in the testing pro-
cess, and that would decrease the count ini-
tially, but because of the poor strength of
the clot, it will get a higher count the se-
cond time. Another problem with platelet
counting is when you get down to really
low levels; debris in the sample (e.g. rup-
tured cells, membranes, etc.) become a sig-
nificant problem and Interferes with the
measurement system (24). On the other
hand, hemolysis due to the breakdown of
P. Baradaran Motie, et al.
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red blood cells is important to the laborato-
ry because it can have an effect on labora-
tory results by increasing them falsely.
Despite our effort, our research faces
some shortcomings which can be improved
in future studies. First of all, the fact that all
of our samples were collected from a single
medical laboratory means that our results
could be affected by the quality of its in-
struments, kits and reagents. Secondly, col-
lected data for some tests such as Phospho-
rus and Magnesium were limited which
could have made some biasness in our re-
sults. Finally, recollected samples were not
available for all of our tests (they were only
available for PTT and INR). Therefore, we
are not able to make a comprehensive com-
parison between initial samples and recol-
lected ones.
As a result of limited time and resources
we were unable to collect data from various
laboratories. It will be beneficial for further
studies to collect data from different labora-
tories, which would be more representative.
Conclusion
At the end, we can say that the result of
our observations is similar to previous stud-
ies. Nowadays, with advanced laboratory
equipments, the routine repeat testing of
critical values has no effect on increasing
the accuracy of the results of these tests.
Repeat testing may be helpful in some situ-
ations, such as when the physician doubts
about the accuracy of a result, or when the
test result is not consistent with the patient's
condition. By ignoring the routine repeat
testing of critical values we can accelerate
the result reporting to caregiver, in addition
to, we can reduce the additional test costs.
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